NCT02331394View on ClinicalTrials.gov

A Feasibility Study of Chinese Herbs to Manage Cancer-related Symptoms in Patients With Advanced NSCLC

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

March 31, 2018

Conditions
Lung Cancer
Interventions
DIETARY_SUPPLEMENT

Chinese herbs formula: Shu Yu Wan

The patients will be offered the choice of taking the CH formula in capsules or sachets and given instructions about recommendations to improve palatability. The formula should be taken with meals 3 times a day (each dose is either 1 sachet or 4 capsules) for six-weeks.

Trial Locations (1)

H3T 1E2

Peter Brojge Lung Cancer Center, Jewish General Hospital, Montreal

All Listed Sponsors
lead

Lady Davis Institute

OTHER

NCT02331394 - A Feasibility Study of Chinese Herbs to Manage Cancer-related Symptoms in Patients With Advanced NSCLC | Biotech Hunter | Biotech Hunter